Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Angiographic outcome in patients treated with deferred stenting after ST-segment elevation myocardial infarction-results from DANAMI-3-DEFER

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Targeted temperature management after out of hospital cardiac arrest: quo vadis?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeartVR trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Symptoms reported in calls to emergency medical services within 24 hours prior to out-of-hospital cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: Stent implantation during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) occasionally results in flow disturbances and distal embolization, which may cause adverse clinical outcomes. Deferred stent implantation seems to reduce the impairment on myocardial function, although the mechanisms have not been clarified. We sought to evaluate whether deferred stenting could reduce flow disturbance in patients treated with primary PCI.

METHODS AND RESULTS: Patients with STEMI included in the DANAMI-3-DEFER trial were randomized to deferred versus immediate stent implantation. The primary and secondary outcomes of this substudy were the incidences of slow/no reflow and distal embolization. A total of 1205 patients were included. Deferred stenting (n = 594) resulted in lower incidences of distal embolization [odds ratio (OR) 0.67, 95% confidence interval (CI) 0.46-0.98, P = 0.040] and slow/no reflow (OR 0.60, 95%CI 0.37-0.97, P = 0.039). In high-risk subgroups, the protective effect was greatest in patients >65 years of age (slow/no reflow: OR 0.36, 95% CI 0.17-0.72, P = 0.004 and distal embolization: OR 0.34, 95% CI 0.18-0.63, P = 0.001), in patients presenting with occluded culprit artery at admission (slow/no reflow: OR 0.33, 95% CI 0.16-0.65, P = 0.001 and distal embolization: OR 0.54, 95% CI 0.31-0.96, P = 0.036) and in patients with thrombus grade >3 (slow/no reflow: OR 0.37, 95% CI 0.20-0.67, P = 0.001 and distal embolization: OR 0.39, 95% CI 0.24-0.64, P < 0.001) with a significant P for interaction for all.

CONCLUSION: Deferred stent implantation reduces the incidences of slow/no reflow and distal embolization, especially in older patients and in those with total coronary occlusion or high level of thrombus burden.

Original languageEnglish
JournalEuropean heart journal. Acute cardiovascular care
Volume11
Issue number10
Pages (from-to)742-748
Number of pages7
ISSN2048-8726
DOIs
Publication statusPublished - 2 Nov 2022

Bibliographical note

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

    Research areas

  • Aged, Coronary Angiography/methods, Humans, Myocardium, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction/diagnosis, Stents, Treatment Outcome

ID: 84177351